Eli Lilly inks another radiopharma deal, gaining option to buy …

Jul 1, 2024 · Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 …

CouponFollow Extension

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy …

4 weeks from now

biopharmadive.com

$1.16
OFF

Lilly Inks Potential $1.16B Deal With Radiopharma Startup

4 weeks from now

May 21, 2024 · Eli Lilly made its foray into the radiopharma space late last year, when the drugmaker paid $1.4 billion to pick up POINT Biopharma. POINT, whose lead candidate is …

pharmamanufacturing.com

$1
OFF

Eli Lilly Jumps Into Radiopharmaceuticals Via $1.4B Point …

4 weeks from now

Oct 3, 2023 · Eli Lilly’s scope in cancer is expanding to radiopharmaceuticals with the $1.4 billion acquisition of Point Biopharma Global, a company in late-stage clinical development with two …

medcitynews.com

$1
OFF

Lilly To Enter Radiopharmaceutical Drug Field With $1.4B Point Buyout

4 weeks from now

Oct 3, 2023 · Eli Lilly is making a bet on radiopharmaceutical drugs for cancer, announcing Tuesday a deal to buy Point Biopharma and its pipeline of experimental therapies for …

biopharmadive.com

$60
OFF

Lilly Pays Aktis $60M To Further Dial Into Radiopharma Signal

4 weeks from now

May 21, 2024 · Lilly established itself as a player in the nascent radiopharma space by acquiring Point Biopharma for $1.4 billion late last year. The takeover included a manufacturing plant, …

fiercebiotech.com

$1
OFF

How Novartis Is Disrupting Lilly's $1.4B Radiotherapy Plan - Fierce …

4 weeks from now

Dec 5, 2023 · On Oct. 3, Eli Lilly unveiled a $1.4 billion agreement to acquire cross-town radiopharmaceutical company Point Biopharma Global to beef up its oncology capabilities. …

fiercebiotech.com

FAQs about Eli Lilly inks another radiopharma deal, gaining option to buy … Coupon?

Will Eli Lilly buy radionetics oncology?

Scott Olson via Getty Images Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 billion. Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. ...

How much will Lilly pay radionetics?

Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. ...

Will Lilly buy radionetics?

Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. Radionetics is developing small molecule radiopharmaceuticals that can target G protein-coupled receptors, a ubiquitous family of proteins that present many attractive disease targets. ...

Will Eli Lilly buy point Biopharma?

Eli Lilly is making a bet on radiopharmaceutical drugs for cancer, announcing Tuesday a deal to buy Point Biopharma and its pipeline of experimental therapies for approximately $1.4 billion. Per acquisition terms, Lilly will pay $12.50 per Point share, a premium of about 87% to what the biotechnology company’s stock closed at Monday. ...

Why is Lilly partnering with a pharma company to develop radiopharma?

Recent improvements in manufacturing and supplying the complex treatments have boosted investment in the field, drawing interest from large pharma companies like Lilly as well as new drug startups. The Point deal appears to be part of a broader plan by Lilly to build a presence in radiopharma drug development. ...

Where is Eli Lilly headquartered 2024?

A sign bearing Eli Lilly’s logo sits outside of the company’s headquarters on March 17, 2024 in Indianapolis, Indiana. Scott Olson via Getty Images Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 billion. ...